21:17 EST Cathie Wood’s ARK Investment buys 291K shares of Beam Therapeutics (BEAM) today
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics price target raised to $37 from $34 at Clear Street
- Cathie Wood Steps Up Bet on Bullish Stock (BLSH), Trims Stake in Palantir (PLTR) amid Strong Q3 Earnings
- Beam Therapeutics reports Q3 EPS ($1.10), consensus ($1.03)
- Promising Potential of BEAM-101 in Sickle Cell Treatment Justifies Buy Rating
- Cathie Wood’s ARK Investment buys 336K shares of Beam Therapeutics today